Calliditas Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(10.5%),BVF Inc.(10.5%), etc.
Calliditas Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fjärde AP-fonden (Fourth Swedish National Pension Fund)(4.5%)
Calliditas Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Swedbank Robur Fonder AB(0.0%)
Calliditas Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Linc AB(10.5%),Bengt Julander(10.5%)
Calliditas Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Fjärde AP-fonden (Fourth Swedish National Pension Fund)(5.1%)
Calliditas Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Swedbank Robur Fonder AB(5.04%)
Calliditas Therapeutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Calliditas Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
No Data